These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1586153)

  • 1. Effects of deferrioxamine on iron-catalyzed lipid peroxidation.
    Miller DM; Spear NH; Aust SD
    Arch Biochem Biophys; 1992 Jun; 295(2):240-6. PubMed ID: 1586153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of ascorbate-dependent, iron-catalyzed lipid peroxidation.
    Miller DM; Aust SD
    Arch Biochem Biophys; 1989 May; 271(1):113-9. PubMed ID: 2712569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthine oxidase- and iron-dependent lipid peroxidation.
    Miller DM; Grover TA; Nayini N; Aust SD
    Arch Biochem Biophys; 1993 Feb; 301(1):1-7. PubMed ID: 8382902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of in vitro lipid peroxidation by 21-aminosteroids. Evidence for differential mechanisms.
    Ryan TP; Steenwyk RC; Pearson PG; Petry TW
    Biochem Pharmacol; 1993 Sep; 46(5):877-84. PubMed ID: 8373438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NADPH- and adriamycin-dependent microsomal release of iron and lipid peroxidation.
    Minotti G
    Arch Biochem Biophys; 1990 Mar; 277(2):268-76. PubMed ID: 2310194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of iron-catalyzed DNA and lipid oxidation.
    Djuric Z; Potter DW; Taffe BG; Strasburg GM
    J Biochem Mol Toxicol; 2001; 15(2):114-9. PubMed ID: 11284053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of lipid peroxidation promoted by iron(III) and ascorbate.
    Beach DC; Giroux E
    Arch Biochem Biophys; 1992 Sep; 297(2):258-64. PubMed ID: 1323241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxygen reduction and lipid peroxidation by iron chelates with special reference to ferric nitrilotriacetate.
    Hamazaki S; Okada S; Li JL; Toyokuni S; Midorikawa O
    Arch Biochem Biophys; 1989 Jul; 272(1):10-7. PubMed ID: 2500058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox cycling of iron and lipid peroxidation.
    Minotti G; Aust SD
    Lipids; 1992 Mar; 27(3):219-26. PubMed ID: 1326072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells.
    Huang X; Dai J; Fournier J; Ali AM; Zhang Q; Frenkel K
    Free Radic Biol Med; 2002 Jan; 32(1):84-92. PubMed ID: 11755320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid peroxidation of rabbit small intestinal microvillus membrane vesicles by iron complexes.
    Fodor I; Marx JJ
    Biochim Biophys Acta; 1988 Jul; 961(1):96-102. PubMed ID: 3132985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate.
    Santos NC; Castilho RF; Meinicke AR; Hermes-Lima M
    Eur J Pharmacol; 2001 Sep; 428(1):37-44. PubMed ID: 11779035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel membrane localized iron chelators as inhibitors of iron-dependent lipid peroxidation.
    Braughler JM; Burton PS; Chase RL; Pregenzer JF; Jacobsen EJ; VanDoornik FJ; Tustin JM; Ayer DE; Bundy GL
    Biochem Pharmacol; 1988 Oct; 37(20):3853-60. PubMed ID: 3190732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of Fe(II)ATP complex-induced damage to the rat liver mitochondrial membrane.
    Hermes-Lima M; Castilho RF; Meinicke AR; Vercesi AE
    Mol Cell Biochem; 1995 Apr; 145(1):53-60. PubMed ID: 7659078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox cycling and lipid peroxidation: the central role of iron chelates.
    Bucher JR; Tien M; Morehouse LA; Aust SD
    Fundam Appl Toxicol; 1983; 3(4):222-6. PubMed ID: 6414871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ceruloplasmin on superoxide-dependent iron release from ferritin and lipid peroxidation.
    Samokyszyn VM; Reif DW; Miller DM; Aust SD
    Free Radic Res Commun; 1991; 12-13 Pt 1():153-9. PubMed ID: 1649082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.
    Kameyama Y; Gemba M
    Jpn J Pharmacol; 1991 Oct; 57(2):259-62. PubMed ID: 1812305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation.
    Miura A; Tampo Y; Yonaha M
    Biochem Mol Biol Int; 1995 Sep; 37(1):141-50. PubMed ID: 8653076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical.
    Andorn AC; Britton RS; Bacon BR
    J Neurochem; 1996 Aug; 67(2):717-22. PubMed ID: 8764600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A chelator is required for microsomal lipid peroxidation following reductive ferritin-iron mobilisation.
    Goddard JG; Gower JD; Green CJ
    Free Radic Res Commun; 1992; 17(3):177-85. PubMed ID: 1459490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.